PE20030697A1 - Derivados de tetrahidrobenzofluoreno - Google Patents

Derivados de tetrahidrobenzofluoreno

Info

Publication number
PE20030697A1
PE20030697A1 PE2002001231A PE2002001231A PE20030697A1 PE 20030697 A1 PE20030697 A1 PE 20030697A1 PE 2002001231 A PE2002001231 A PE 2002001231A PE 2002001231 A PE2002001231 A PE 2002001231A PE 20030697 A1 PE20030697 A1 PE 20030697A1
Authority
PE
Peru
Prior art keywords
alkyl
derivatives
hydroxy
tetrahidrobenzofluoreno
alkenyl
Prior art date
Application number
PE2002001231A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20030697A1 publication Critical patent/PE20030697A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J69/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A DERIVADOS DE TETRAHIDROBENZOFLUORENO DE FORMULA I DONDE EL SUSTITUYENTE O-(CH2)n-N(R1R2) EN EL ANILLO PUEDE ESTAR EN POSICION META O PARA; n ES 2-4; Re Y Re' SON OH, R1 Y R2 SON ALQUILO, ALQUENILO, HIDROXI-ALQUILO, ALCOXI-ALQUILO, ARILO-ALQUILO O JUNTO A N FORMA UN HETEROCICLO OPCIONALMENTE SUSTITUIDO CON ALQUILO, ALQUENILO, HIDROXI-ALQUILO, ALCOXI-ALQUILO, ARILO. LOS COMPUESTOS SON ANTAGONISTAS DE RECEPTORES DE ESTROGENOS ß Y PUEDEN SER UTILES PARA ALIVIAR LOS MALESTARES TIPICOS ASOCIADOS CON LA MENOPAUSIA
PE2002001231A 2001-12-21 2002-12-13 Derivados de tetrahidrobenzofluoreno PE20030697A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01205206 2001-12-21

Publications (1)

Publication Number Publication Date
PE20030697A1 true PE20030697A1 (es) 2003-08-18

Family

ID=8181558

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001231A PE20030697A1 (es) 2001-12-21 2002-12-13 Derivados de tetrahidrobenzofluoreno

Country Status (11)

Country Link
US (2) US7304155B2 (es)
EP (1) EP1458743B1 (es)
JP (1) JP5054882B2 (es)
AR (1) AR038035A1 (es)
AT (1) ATE382628T1 (es)
AU (1) AU2002358715A1 (es)
DE (1) DE60224441T2 (es)
ES (1) ES2298414T3 (es)
PE (1) PE20030697A1 (es)
TW (1) TW200408385A (es)
WO (1) WO2003053994A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200408385A (en) * 2001-12-21 2004-06-01 Akzo Nobel Nv Tetrahydrobenzfluorene derivatives
WO2008091555A2 (en) 2007-01-22 2008-07-31 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147880A (en) * 1991-07-22 1992-09-15 Eli Lilly And Company Benzo[a]fluorene compounds
WO2001072713A1 (en) 2000-03-27 2001-10-04 Akzo Nobel N.V. Non-steroidal, tetracyclic compounds for estrogen-related treatments
TW200408385A (en) * 2001-12-21 2004-06-01 Akzo Nobel Nv Tetrahydrobenzfluorene derivatives

Also Published As

Publication number Publication date
DE60224441T2 (de) 2008-12-11
AR038035A1 (es) 2004-12-22
DE60224441D1 (de) 2008-02-14
US7655653B2 (en) 2010-02-02
US7304155B2 (en) 2007-12-04
AU2002358715A1 (en) 2003-07-09
EP1458743A1 (en) 2004-09-22
US20050119264A1 (en) 2005-06-02
ES2298414T3 (es) 2008-05-16
WO2003053994A1 (en) 2003-07-03
US20080058361A1 (en) 2008-03-06
JP2005518387A (ja) 2005-06-23
JP5054882B2 (ja) 2012-10-24
ATE382628T1 (de) 2008-01-15
TW200408385A (en) 2004-06-01
EP1458743B1 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
AR043111A1 (es) Derivados monoacilados de o-fenilendiaminas
AR020851A2 (es) Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos
CO5261578A1 (es) Inhibidores de nitrilo de dipeptido catepsina k.
AR016817A1 (es) Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
PE20010126A1 (es) Pirrolotriazinas como inhibidores de cinasas
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
CR11263A (es) COMPUESTOS NOVEDOSOS QUE POSEEN ACTIVIDAD INNHIBITORIA CONTRA TRANSPORTADOR DE GLUCOSA DEPENDIENTE DE SODIO (Solicitud divisional)
PE20040165A1 (es) Uso de analogos del benzimidazol en el tratamiento de la proliferacion celular
WO2003024441A1 (fr) Nouvelle utilisation de composes tricycliques
CO5170512A1 (es) Derivados de tetrahidroquinolin piperidina
PT1427280E (pt) Novos compostos
PE20030697A1 (es) Derivados de tetrahidrobenzofluoreno
CO5160260A1 (es) Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido
CO5130006A1 (es) Compuestos de pirazina
NO179947C (no) Indanderivater
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
MX9206127A (es) Compuestos de acetileno
ES2107505T3 (es) Derivados de bencimidazol, un metodo para producirlo, fungicidas agricolas y horticolas que lo contienen como ingrediente activo y compuestos intermedios en su preparacion.
NZ220987A (en) Carbamate and urea derivatives and pharmaceutical compositions thereof
ECSP077385A (es) 4-[(2,4-dicloro-5-metoxifenil)amino]-6-alcoxi-7-etinil-3-quinolinocarbonitrilos para el tratamiento de lesión isquémica
PE20040160A1 (es) 1,2-dihidropirazol-3-onas que controlan citoquinas inflamatorias
ES2136851T3 (es) Granulados tensioactivos heterogeneos.
CO5090902A1 (es) Pirroles sustituidos
KR910006491A (ko) Ll-f28249 화합물의 13-알킬-23-23이미노 및 13-할로-23-이미노 유도체 및 그의 사용

Legal Events

Date Code Title Description
FA Abandonment or withdrawal